Anlon Healthcare Ltd. Stock Analysis AHCL.NS

Anlon Healthcare Ltd is a IN-based company operating in Pharmaceuticals industry. The company is headquartered in Rajkot, Gujarat. The company went IPO on 2025-09-03. Anlon Healthcare Limited is an India-based company, which is engaged in the business of manufacturing of high purity advance pharmaceutical intermediates (Pharma Intermediate) which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients and active pharmaceutical ingredients (APIs) which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula (FDF), such as tablet, capsules, ointment, syrup, and ingredients in nutraceuticals formulations, personal care products and animal health products. Its products span across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API. Its products include 3-(1-cyanoethyl) benzoic acid (CEBA), ketoprofen ethyl ester (KEE), Dex-Ketoprofen, Loxoprofen Acid, Ketoprofen, Silodosin, Omeprazole, L-Arginine, Piroctone olamine, Ticagrelor, and others.